Intervention Review

You have free access to this content

Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children

  1. Diane M Gray1,*,
  2. Taryn Young2,
  3. Mark Cotton3,
  4. Heather Zar4

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 20 MAR 2006

DOI: 10.1002/14651858.CD006418.pub2

Database Title

Additional Information

How to Cite

Gray DM, Young T, Cotton M, Zar H. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006418. DOI: 10.1002/14651858.CD006418.pub2.

Author Information

  1. 1

    Groote Schuur Hospital, G25 HIV/AIDS Paediatric Service, Cape Town, Western Cape, South Africa

  2. 2

    Medical Research Council, South African Cochrane Centre, Tygerberg, South Africa

  3. 3

    Tygerberg Children's Hospital, Children's Infectious Diseases Clinical Research, Tygerberg, Cape Provice, South Africa

  4. 4

    University of Cape Town, 5th floor ICH Building, Department of Paediatric Pulmonology, School of Child and Adolescent Health, Red Cross Childrens Hospital, Capre Town, South Africa

*Diane M Gray, G25 HIV/AIDS Paediatric Service, Groote Schuur Hospital, Cape Town, Western Cape, 7700, South Africa. diane@kidzpositive.org. graysteven@mweb.co.za.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (201K)Full (211K)
[Analysis 1.4]
Analysis 1.4. Comparison 1 Isoniazid versus placebo, Outcome 4 Hazard ratio death.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Isoniazid versus placebo, Outcome 5 Hazard ratio TB incidence.
View Full Article (HTML) Summary (61K)Standard (201K)Full (211K)